Intrathecal dexmedetomidine
Intrathecal dexmedetomidine is a pharmaceutical drug with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section
Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty
Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections
Dexamethasone and Dexmedetomidine as an Adjuvant to Spinal Anesthesia for Elective Caesarean Sections
Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate
Clinical Trials (8)
Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section
Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty
Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections
Dexamethasone and Dexmedetomidine as an Adjuvant to Spinal Anesthesia for Elective Caesarean Sections
Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate
Effect of Intrathecal vs Intraarticular Dexmedetomidine on Postoperative Pain Following Arthroscopy
Comparison of Different Doses of Dexmedetomidine Effect in the Duration of Spinal Anesthesia
Optimal Single Dose Intrathecal Dexmedetomidine for Postoperative Analgesia
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8